Diabetes

Screening diabetic neuropathy with SUDOSCAN in type 2 diabetes and prediabetes

Screening diabetic neuropathy with SUDOSCAN in type 2 diabetes and prediabetes   Juan J. Cabré, Teresa Mur, Bernardo Costa, Francisco Barrio, Charo López-Moya, Ramon Sagarra, Montserrat García-Barco, Jesús Vizcaíno, Immaculada  Bonaventura, Nicolau Ortiz, Gemma Flores-Mateo, Oriol Solà-Morales and the Catalan Diabetes Prevention Research Group. Article title: Feasibility and Effectiveness of Electrochemical Dermal Conductance Measurement for …

Screening diabetic neuropathy with SUDOSCAN in type 2 diabetes and prediabetes Read More »

SUDOSCAN in cardiovascular autonomic neuropathy screening

SUDOSCAN in cardiovascular autonomic neuropathy screening Yun-Ru Lai, Chih-Cheng Huang, Ben-Chung Cheng, Nai-Wen Tsai, Wen-Chan Chiu, Hsueh-Wen Chang, Jung-Fu Chen, Cheng-Hsien Lu. Article title: Feasibility of combining heart rate variability and electrochemical skin conductance as screening and severity evaluation of cardiovascular autonomic neuropathy in type 2 diabetes.Muscle Nerve. 2021 Apr 1 YR Lai et al from …

SUDOSCAN in cardiovascular autonomic neuropathy screening Read More »

SUDOSCAN utility to detect foot sudomotor dysfunction in type 1 diabetes without clinical evidence of peripheral neuropathy

SUDOSCAN UTILITY TO DETECT FOOT SUDOMOTOR DYSFUNCTION IN TYPE 1 DIABETES WITHOUT CLINICAL EVIDENCE OF PERIPHERAL NEUROPATHY   Danyelle Lorrane Carneiro Veloso, Raira Castilho Gomes Nascimento, Eliziane Brandao Leite, Luisiane de Avila Santana, Angelica Amorim Amato.Article title: Predictors of sudomotor dysfunction in patients with type 1 diabetes without clinical evidence of peripheral neuropathy.Diabetes Research and Clinical …

SUDOSCAN utility to detect foot sudomotor dysfunction in type 1 diabetes without clinical evidence of peripheral neuropathy Read More »

Clinical impact of dpp-4 inhibitor on autonomic neuropathy followed up by SUDOSCAN

CLINICAL IMPACT OF DPP-4 INHIBITOR ON AUTONOMIC NEUROPATHY FOLLOWED UP BY SUDOSCAN​ A. Syngle, S. Chahal, K. Vohra. Article title: Efficacy and tolerability of DPP4 inhibitor, teneligliptin, on autonomic and peripheral neuropathy in type 2 diabetes: an open label, pilot study. Neurological Sciences. 2020 Aug 15. A new publication by Syngle et al. in Neurological …

Clinical impact of dpp-4 inhibitor on autonomic neuropathy followed up by SUDOSCAN Read More »

Website dedicated
to health professionals

I am a health professional

To receive our latest scientific news:

Scroll to Top